CCR5 and HIV-1 infection: To explore whether TGF-β signaling contributed to the increase in HIV-1 infection associated with upregulation of GPC1, we treated GPC1 overexpressing cells or alkyl-CIMSS treated Jurkat-CCR5 cells with SB431542, a pharmacological inhibitor of TGF-β signaling [16].